List of Tables
Table 1. Global Market Natural Killer (NK) Cell Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
Table 40. Global Natural Killer (NK) Cell Therapeutics Key Players Headquarters and Area Served
Table 41. Natural Killer (NK) Cell Therapeutics Product Solution and Service
Table 42. Global Natural Killer (NK) Cell Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Chipscreen Biosciences Basic Information List
Table 45. Chipscreen Biosciences Description and Business Overview
Table 46. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Chipscreen Biosciences (2018-2023)
Table 48. Chipscreen Biosciences Recent Developments
Table 49. Affimed NV Basic Information List
Table 50. Affimed NV Description and Business Overview
Table 51. Affimed NV Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Affimed NV (2018-2023)
Table 53. Affimed NV Recent Developments
Table 54. Altor BioScience Basic Information List
Table 55. Altor BioScience Description and Business Overview
Table 56. Altor BioScience Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Altor BioScience (2018-2023)
Table 58. Altor BioScience Recent Developments
Table 59. Innate Pharma Basic Information List
Table 60. Innate Pharma Description and Business Overview
Table 61. Innate Pharma Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Innate Pharma (2018-2023)
Table 63. Innate Pharma Recent Developments
Table 64. Takeda Basic Information List
Table 65. Takeda Description and Business Overview
Table 66. Takeda Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Takeda (2018-2023)
Table 68. Takeda Recent Developments
Table 69. Sorrento Therapeutics Basic Information List
Table 70. Sorrento Therapeutics Description and Business Overview
Table 71. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Sorrento Therapeutics (2018-2023)
Table 73. Sorrento Therapeutics Recent Developments
Table 74. NantKwest Basic Information List
Table 75. NantKwest Description and Business Overview
Table 76. NantKwest Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of NantKwest (2018-2023)
Table 78. NantKwest Recent Developments
Table 79. Bristol-Myers Squibb Basic Information List
Table 80. Bristol-Myers Squibb Description and Business Overview
Table 81. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Bristol-Myers Squibb (2018-2023)
Table 83. Bristol-Myers Squibb Recent Developments
Table 84. NKT Basic Information List
Table 85. NKT Description and Business Overview
Table 86. NKT Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of NKT (2018-2023)
Table 88. NKT Recent Developments
Table 89. Henry Ford Health Services Basic Information List
Table 90. Henry Ford Health Services Description and Business Overview
Table 91. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Henry Ford Health Services (2018-2023)
Table 93. Henry Ford Health Services Recent Developments
Table 94. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2018-2023)
Table 102. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2024-2029)
Table 103. Latin America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 109. Natural Killer (NK) Cell Therapeutics Market Trends
Table 110. Natural Killer (NK) Cell Therapeutics Market Drivers
Table 111. Natural Killer (NK) Cell Therapeutics Market Challenges
Table 112. Natural Killer (NK) Cell Therapeutics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer (NK) Cell Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Mogamulizumab
Figure 11. Global Mogamulizumab Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Lorvotuzumab Mertansine
Figure 13. Global Lorvotuzumab Mertansine Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Type: 2022 & 2029
Figure 17. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
Figure 18. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Cardiovascular Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Application: 2022 & 2029
Figure 26. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
Figure 27. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
Figure 28. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
Figure 29. Latin America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
Figure 30. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
Figure 31. Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Natural Killer (NK) Cell Therapeutics Market Share in 2022
Figure 33. North America Natural Killer (NK) Cell Therapeutics Market Share by Country (2018-2029)
Figure 34. U.S. Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 35. Canada Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 36. Germany Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 37. France Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. U.K. Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Italy Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. Russia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 42. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2018-2029)
Figure 43. China Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. Japan Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. South Korea Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. India Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. Australia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 49. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Country (2018-2029)
Figure 50. Mexico Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. Brazil Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Country (2018-2029)
Figure 53. Turkey Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 55. UAE Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report